Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Aditya Puri appointed as Director of Stelis Biopharma, Advisor to Strides Group

Ruchika Sharma8 Jan 2021 11:55 AM IST

Bengaluru: Strides Pharma Science Limited announced that eminent corporate doyen Aditya Puri joins the Strides Group as an Advisor and also will be a...

Lupin bags tentative USFDA nod for rare autoimmune disorder drug Amifampridine

Lupin gets USFDA nod for Empagliflozin, Metformin Hydrochloride ER Tablets

Ruchika Sharma8 Jan 2021 11:19 AM IST

Mumbai, Baltimore: Drugmaker, Lupin Limited, has recently announced that the company has received tentative approval for its Empagliflozin and...

Pfizer, AstraZeneca working with Britain to increase COVID-19 vaccine supplies

Ruchika Sharma8 Jan 2021 9:15 AM IST

The government must ramp up the shots to around 2 million a week to hit its target.

Moberg Pharma subsidiary announces issue of European Patent related to BupiZenge

Ruchika Sharma8 Jan 2021 9:00 AM IST

The new patent protects sustained release lozenge containing bupivacaine, for treatment or alleviation of pain in the oral cavity.

New use of Pfizer vaccine increasing doses by 20 percent may soon get EU go ahead: Report

Ruchika Sharma7 Jan 2021 12:44 PM IST

Brussels: The European drugs regulator could soon give the go ahead for an extra sixth dose to be extracted from Pfizer-BioNTech COVID-19 vaccine...

Moderna COVID-19 vaccine gets European Commission okay

Ruchika Sharma7 Jan 2021 12:10 PM IST

Cambridge: Moderna Inc. has recently announced that the European Commission has granted a conditional marketing authorization (CMA) for...

Lupin gets USFDA nod for generic equivalent of Bactrim Oral Suspension

Ruchika Sharma7 Jan 2021 12:06 PM IST

Mumbai, Baltimore: Drugmaker, Lupin Limited, has recently announced that the company has received approval for its Sulfamethoxazole and...

AstraZeneca gets USFDA Priority Review for Farxiga to treat chronic kidney disease

Ruchika Sharma7 Jan 2021 12:00 PM IST

CKD, a condition defined by decreased kidney function, is often associated with a heightened risk of heart disease or stroke, or the need for dialysis...

Scientists to see if Moderna COVID-19 vaccine doses can be halved to double supply in US

Ruchika Sharma6 Jan 2021 1:46 PM IST

The FDA said on Monday the idea of changing the authorized dosing or schedules of COVID-19 vaccines was premature and not supported by available data.

All Covid-19 vaccines to be stored at 2-8 degrees Celsius: Dept of Biotechnology

Ruchika Sharma6 Jan 2021 1:10 PM IST

New Delhi: All Indian vaccines being developed against the coronavirus can be stored at 2-8 degrees Celsius as the logistics have been worked out...

AstraZeneca completes divestment of heart failure, hypertension brand Atacand to Cheplapharm

Ruchika Sharma6 Jan 2021 12:59 PM IST

New Delhi: AstraZeneca has recently announced that the company has completed the divestment of commercial rights to Atacand (candesartan cilexetil)...

Pfizer COVID-19 vaccine approved by Colombian regulator for emergency use

Ruchika Sharma6 Jan 2021 12:00 PM IST

Bogota: Colombia's food and drug regulator on Tuesday authorized emergency use of Pfizer Inc and BioNTech SE's COVID-19 vaccine, President Ivan Duque...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok